Skip to main content
Quest Diagnostics

Myeloma

Complete myeloma testing can provide earlier diagnostic insights

When it comes to multiple myeloma, earlier detection means better outcomes. Quest multiple myeloma testing supports your patients through every stage of their cancer journey—from detection to diagnosis to posttreatment monitoring.

Now available! Flow Cytometry MRD for Myeloma, an ultra-sensitive test for assessing residual disease (MRD) in patients with myeloma

Flow MRD for Myeloma is raising the standard for patient care

  • Multi-parameter flow cytometry, validated for monitoring minimal residual disease (MRD) in peripheral blood of patients with myeloma
  • Assay sensitivity = 5 x 10-6 with only a single tube of blood
  • No baseline sample required—initiate testing at any time
  • Rapid 3-5 days turnaround time with enhanced, integrated reporting

Flow MRD for Myeloma by Quest Diagnostics merges elite performance with value and access, making it a great option for value-based care. This new offering complements Quest’s  comprehensive portfolio of hematopathology and advanced molecular oncology testing and services.

Myeloma tests

Flow Cytometry MRD
Myeloma Detection Panel, Basic
Myeloma Detection Panel, Comprehensive

This information is provided for informational purposes only and is not intended as medical advice. A physician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Get in touch

775

* indicates required

Cancer

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.